Results 211 to 220 of about 338,615 (308)

Antineoplastic agent-associated interstitial lung disease in breast, ovarian, and prostate cancers: a pharmacovigilance study using the FDA adverse event reporting system. [PDF]

Front Immunol
Du K, Duan C, Zhang J, Zhang J, Du J, Pan Y, Liu Z, Zhang C, Zhang Y, Zhang Y, Zhang X, Sheng Z, Wang B, Ren Y, Zhu L.   +14 more
europepmc   +1 more source

The effects of royal jelly on human health: A narrative review of clinical studies

JSFA reports, EarlyView.
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Georgios Goras, Andreas Thrasyvoulou, Evanthia Tsilimpokou   +2 more
wiley   +1 more source

Genome mining strategies to unlock the metabolic potential of <i>Streptomyces</i> sp. VITGV100 (MCC 4961) for next-generation antimicrobial discovery. [PDF]

Front Microbiol
Pattapulavar V, Subburaj S, Ramanujam S, Shil R, Velmurugan P, Ghatak T, Muthusamy S, Samrot AV, Christopher JG.   +8 more
europepmc   +1 more source

Bromelain as the enzyme of the future: A global bibliometric mapping of its applications and emerging trends

Journal of the Science of Food and Agriculture, EarlyView.
Abstract INTRODUCTION Bromelain, a complex mixture of proteolytic enzymes primarily extracted from plants of the Bromeliaceae family, has gained prominence because of its broad industrial applicability, particularly in the food, pharmaceutical and cosmetic sectors.
Genésio José da Silva Neto, Tonny Cley Campos Leite, Mônica Tejo Cavalcanti, Geany Targino Sousa Pedrosa, Rerisson do Nascimento Alves, Amanda Reges de Sena, Mônica Correia Gonçalves   +6 more
wiley   +1 more source

The Role of Pyrrolidine in Antibacterial Drug Discovery: Clinically Approved Antibiotics, Novel Derivatives, and Future Perspectives. [PDF]

Int J Mol Sci
Rusu A, Stroia IM, Hancu G, Tanase C, Uncu L.   +4 more
europepmc   +1 more source

Nail Toxicities Associated With Anticancer Therapies in Children

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley   +1 more source

Sintilimab‑related cystitis/ureteritis in high‑grade endometrial stromal sarcoma: A case report and structured literature review. [PDF]

Hum Vaccin Immunother
Yang S, Gao R, Li D, Shi W, Yang X, Shi P, Qi L, Li W, Zhang Y, Li J.   +9 more
europepmc   +1 more source

Nail Surgery in Children: Specific Challenges and Practical Considerations

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail surgery in children represents a specific field within dermatologic surgery. Although the procedures themselves are largely similar to those performed in adults, the indications, technical constraints, and perioperative management differ substantially. Pediatric nail disorders are often clinically recognizable, which frequently limits the
F. Lamoline, B. Richert
wiley   +1 more source

Observed regression of rapidly growing multifocal squamous cell carcinoma of the face and scalp following initiation of doxycycline. [PDF]

JAAD Case Rep
Fadadu RP, Scerbo SN, Romero LS.
europepmc   +1 more source

532‐nm KTP Laser Treatment of Epidermal Growth Factor Receptor Inhibitor–Associated Paronychia: A Case Report

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives Paronychia is a common and often painful cutaneous adverse event of epidermal growth factor receptor inhibitor therapy that can impair function and quality of life. We report the first known case of amivantamab‐associated paronychia successfully treated with 532‐nm potassium‐titanyl‐phosphate laser.
Emilee M. Dreifus, Aditi Chokshi, Ariel E. Eber   +2 more
wiley   +1 more source